{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:41:03Z","timestamp":1787024463265,"version":"build-2736575974"},"reference-count":32,"publisher":"Oxford University Press (OUP)","issue":"21","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,11,1]]},"DOI":"10.2146\/ajhp160387","type":"journal-article","created":{"date-parts":[[2017,10,25]],"date-time":"2017-10-25T06:35:22Z","timestamp":1508913322000},"page":"1774-1783","source":"Crossref","is-referenced-by-count":12,"title":["Identifying and characterizing preventable adverse drug events for prioritizing pharmacist intervention in hospitals"],"prefix":"10.1093","volume":"74","author":[{"given":"Nakyung","family":"Jeon","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida, Gainesville, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Staley","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Services, UF Health Shands Hospital, Gainesville, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Johns","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Services, UF Health Shands Hospital, Gainesville, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glori Pflugfelder","family":"Lipori","sequence":"additional","affiliation":[{"name":"UF Health Shands Hospital, Gainesville, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Babette","family":"Brumback","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, College of Public Health and Health Professions, and Department of Biostatistics, College of Medicine, University of Florida, Gainesville, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Segal","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida, Gainesville, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Almut G.","family":"Winterstein","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, and Department of Epidemiology, College of Public Health and Health Professions, University of Florida, Gainesville, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","reference":[{"key":"key\n\t\t\t\t2019041103412909600_b1-0741774","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.2146\/ajhp110060","article-title":"The consensus of the Pharmacy Prac-tice Model Summit","volume":"68","year":"2011","journal-title":"Am J Health-Syst Pharm"},{"key":"key\n\t\t\t\t2019041103412909600_b2-0741774","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.2146\/ajhp110148","article-title":"Three signals from the Pharmacy Practice Model Summit","volume":"68","author":"Zellmer","year":"2011","journal-title":"Am J Health-Syst Pharm"},{"key":"key\n\t\t\t\t2019041103412909600_b3-0741774","unstructured":"ASHP Research and Education Foundation. Drug therapy management complexity score index. www.ashpfoundation.org\/MainMenuCategories\/ResearchResourceCenter\/ResearchPublications\/Drug-Therapy-Management-Complexity-Score-Index (accessed 2015 Dec 7)."},{"issue":"suppl 3","key":"key\n\t\t\t\t2019041103412909600_b4-0741774","doi-asserted-by":"crossref","first-page":"S360","DOI":"10.1590\/S0102-311X2009001500003","article-title":"Adverse drug events in hospitals: a systematic review","volume":"25","author":"Cano","year":"2009","journal-title":"Cad Saude Publica"},{"key":"key\n\t\t\t\t2019041103412909600_b5-0741774","doi-asserted-by":"crossref","first-page":"e33236","DOI":"10.1371\/journal.pone.0033236","article-title":"Percentage of patients with preventable adverse drug reactions and preventability of adverse drug reactions: a meta-analysis","volume":"7","author":"Hakkarainen","year":"2012","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t2019041103412909600_b6-0741774","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1007\/s00228-013-1563-z","article-title":"Comparative epidemiology of hospital-acquired adverse drug reactions in adults and children and their impact on cost and hospital stay\u2014a systematic review","volume":"69","author":"Khan","year":"2013","journal-title":"Eur J Clin Pharmacol"},{"key":"key\n\t\t\t\t2019041103412909600_b7-0741774","doi-asserted-by":"crossref","first-page":"379","DOI":"10.2165\/00002018-200730050-00003","article-title":"Drug-related problems in hospitals: a review of the recent literature","volume":"30","author":"Krahenbuhl-Melcher","year":"2007","journal-title":"Drug Saf"},{"key":"key\n\t\t\t\t2019041103412909600_b8-0741774","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1093\/ajhp\/60.17.1750","article-title":"Nature of preventable adverse drug events in hospitals: a literature review","volume":"60","author":"Kanjanarat","year":"2003","journal-title":"Am J Health-Syst Pharm"},{"key":"key\n\t\t\t\t2019041103412909600_b9-0741774","unstructured":"Lucado J Paez K Elixhauser A . Medication-related adverse outcomes in U.S. hospitals and emergency departments, 2008: statistical brief #109. www.hcup-us.ahrq.gov\/reports\/statbriefs\/sb109.pdf (accessed 2017 Aug 2)."},{"key":"key\n\t\t\t\t2019041103412909600_b10-0741774","unstructured":"Joint Commission. Core measure sets. www.jointcommission.org\/core_measure_sets.aspx (accessed 2013 Oct 12)."},{"key":"key\n\t\t\t\t2019041103412909600_b11-0741774","unstructured":"Agency for Healthcare Research and Quality. Joint Commission 2011 National Patient Safety Goals. https:\/\/innovations.ahrq.gov\/qualitytools\/joint-commission-2011-national-patient-safety-goals (accessed 2013 Oct 12)."},{"key":"key\n\t\t\t\t2019041103412909600_b12-0741774","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1093\/ajhp\/59.18.1742","article-title":"Identifying clinically significant preventable adverse drug events through a hospital\u2019s database of adverse drug reaction reports","volume":"59","author":"Winterstein","year":"2002","journal-title":"Am J Health-Syst Pharm"},{"key":"key\n\t\t\t\t2019041103412909600_b13-0741774","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1093\/ajhp\/61.18.1908","article-title":"Nature and causes of clinically significant medication errors in a tertiary care hospital","volume":"61","author":"Winterstein","year":"2004","journal-title":"Am J Health-Syst Pharm"},{"key":"key\n\t\t\t\t2019041103412909600_b14-0741774","doi-asserted-by":"crossref","first-page":"e4439","DOI":"10.1371\/journal.pone.0004439","article-title":"Adverse drug reactions in hospital in-patients: a prospective analysis of 3695 patient-episodes","volume":"4","author":"Davies","year":"2009","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t2019041103412909600_b15-0741774","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s00228-012-1318-2","article-title":"Evaluation of adverse drug reactions in medical intensive care units","volume":"69","author":"Park","year":"2013","journal-title":"Eur J Clin Pharmacol"},{"key":"key\n\t\t\t\t2019041103412909600_b16-0741774","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s00134-010-1778-8","article-title":"Prevention of adverse drug reactions in intensive care patients by personal intervention based on an electronic clinical decision support system","volume":"36","author":"Bertsche","year":"2010","journal-title":"Intensive Care Med"},{"key":"key\n\t\t\t\t2019041103412909600_b17-0741774","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1227\/01.NEU.0000197321.57853.83","article-title":"Prevalence and characteristics of adverse drug reactions in neurosurgical intensive care patients","volume":"58","author":"Smith","year":"2006","journal-title":"Neurosurgery"},{"key":"key\n\t\t\t\t2019041103412909600_b18-0741774","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1097\/CCM.0b013e318236f473","article-title":"Analysis of risk factors for adverse drug events in critically ill patients","volume":"40","author":"Kane-Gill","year":"2012","journal-title":"Crit Care Med"},{"key":"key\n\t\t\t\t2019041103412909600_b19-0741774","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1345\/aph.1H088","article-title":"Adverse drug event reporting in intensive care units: a survey of current practices","volume":"40","author":"Kane-Gill","year":"2006","journal-title":"Ann Pharmacother"},{"key":"key\n\t\t\t\t2019041103412909600_b20-0741774","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1007\/s40266-013-0109-5","article-title":"Prevention of inappropriate prescribing in hospitalized older patients using a computerized prescription support system (INTERcheck)","volume":"30","author":"Ghibelli","year":"2013","journal-title":"Drugs Aging"},{"key":"key\n\t\t\t\t2019041103412909600_b21-0741774","doi-asserted-by":"crossref","first-page":"e71045","DOI":"10.1371\/journal.pone.0071045","article-title":"Adverse drug events in older hospitalized patients: results and reliability of a comprehensive and structured identification strategy","volume":"8","author":"Klopotowska","year":"2013","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t2019041103412909600_b22-0741774","doi-asserted-by":"crossref","first-page":"189","DOI":"10.4103\/0022-3859.85201","article-title":"Frequency and nature of adverse drug reactions in elderly in-patients of two Indian medical college hospitals","volume":"57","author":"Harugeri","year":"2011","journal-title":"J Postgrad Med"},{"key":"key\n\t\t\t\t2019041103412909600_b23-0741774","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S1553-7250(10)36003-X","article-title":"Adverse drug events among hospitalized Medicare patients: epidemiology and national estimates from a new approach to surveillance","volume":"36","author":"Classen","year":"2010","journal-title":"Jt Comm J Qual Patient Saf"},{"key":"key\n\t\t\t\t2019041103412909600_b24-0741774","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.jval.2012.05.007","article-title":"Costs of adverse drug events in German hospitals: a microcosting study","volume":"15","author":"Rottenkolber","year":"2012","journal-title":"Value Health"},{"key":"key\n\t\t\t\t2019041103412909600_b25-0741774","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2146\/ajhp110084","article-title":"Preventability of adverse drug events involving multiple drugs using publicly available clinical decision support tools","volume":"69","author":"Wright","year":"2012","journal-title":"Am J Health-Syst Pharm"},{"key":"key\n\t\t\t\t2019041103412909600_b26-0741774","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.2165\/11592030-000000000-00000","article-title":"Preventable and non-preventable adverse drug events in hospitalized patients: a prospective chart review in the Netherlands","volume":"34","author":"Dequito","year":"2011","journal-title":"Drug Saf"},{"key":"key\n\t\t\t\t2019041103412909600_b27-0741774","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1001\/archinte.165.10.1111","article-title":"High rates of adverse drug events in a highly computerized hospital","volume":"165","author":"Nebeker","year":"2005","journal-title":"Arch Intern Med"},{"key":"key\n\t\t\t\t2019041103412909600_b28-0741774","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.26719\/2009.15.5.1145","article-title":"Prevalence and prevent-ability of adverse drug events in a teaching hospital: a cross-sectional study","volume":"15","author":"Benkirane","year":"2009","journal-title":"East Mediterr Health J"},{"key":"key\n\t\t\t\t2019041103412909600_b29-0741774","first-page":"39","article-title":"Prevalence and assessment of factors contributing to adverse drug reactions in wards of a tertiary care hospital, India","volume":"23","author":"Haile","year":"2013","journal-title":"Ethiop J Health Sci"},{"key":"key\n\t\t\t\t2019041103412909600_b30-0741774","unstructured":"Office of Disease Prevention and Health Promotion. National action plan for adverse drug event prevention. www.health.gov\/hcq\/pdfs\/ADE-Action-Plan-508c.pdf (accessed 2013 Oct 12)."},{"key":"key\n\t\t\t\t2019041103412909600_b31-0741774","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s11606-012-2229-8","article-title":"Hospital performance measures and 30-day readmission rates","volume":"28","author":"Stefan","year":"2013","journal-title":"J Gen Intern Med"},{"key":"key\n\t\t\t\t2019041103412909600_b32-0741774","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1111\/j.1365-2929.2004.02012.x","article-title":"Likert scales: how to (ab) use them","volume":"38","author":"Jamieson","year":"2004","journal-title":"Med Educ"}],"container-title":["American Journal of Health-System Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajhp\/article-pdf\/74\/21\/1774\/28336715\/ajhp1774.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,5]],"date-time":"2022-08-05T05:45:08Z","timestamp":1659678308000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajhp\/article\/74\/21\/1774\/5102675"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,1]]},"references-count":32,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2017,11,1]]}},"URL":"https:\/\/doi.org\/10.2146\/ajhp160387","relation":{},"ISSN":["1079-2082","1535-2900"],"issn-type":[{"value":"1079-2082","type":"print"},{"value":"1535-2900","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,11,1]]},"published":{"date-parts":[[2017,11,1]]}}}